Caeruleus Genomics
Peter Crane is currently the Co-Founder and CEO of Caeruleus Genomics, where Peter pioneers long-read-based tissue profiling for novel therapeutics. Peter also serves as a Venture Partner at Lunar Ventures, focusing on investments at the intersection of computer science and biology/chemistry. Additionally, Peter has held leadership roles in companies such as Infinitopes and Synthace, bringing a wealth of experience in strategy development and corporate management. With a background in Chemical Biology and Chemistry from the University of Oxford and University of Warwick, Peter has a solid foundation for their work in the biotech and venture capital industries.
This person is not in any teams
Caeruleus Genomics
Caeruleus Genomics has developed a proprietary discovery platform to profile disease multimodally and with unprecedented accuracy. To do this, we overcame the core bottlenecks to industrialising single-cell long-read sequencing. We use our in-house computational and sequencing platform to profile human tissues functionally, uncover new RNA targets and develop more effective therapies in oncology and rare diseases. Spun out from Oxford University by experts in functional genomics, therapeutic target discovery and computational biology.